Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a small update to the page’s versioning or metadata rather than any changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-07T02:56:52.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a software update to the page rendering. This likely reflects backend/frontend improvements and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:42:31.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note have been added. The Intervention/Treatment label remains visible and the revision version updated to v3.6.0, reflecting a refresh of the study details and navigation.
    Difference
    0.5%
    Check dated 2026-06-15T08:20:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.5.4 to v3.5.5, reflecting a version update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-08T04:15:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a new release version; no substantive changes to the displayed study information are evident.
    Difference
    0.1%
    Check dated 2026-05-17T10:14:31.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a maintenance or platform update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:52:01.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.